Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Blood Advances|November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Donald M Arnold, James B Bussel, et al.
Arthritis and Rheumatism|October 10, 2012
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohortCloé Comarmond, Christian Pagnoux, Mehdi Khellaf, et al.
American Journal of Hematology|September 7, 2019
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-rituxSamuel Deshayes, Mehdi Khellaf, Anissa Zarour, et al.
Rheumatology (Oxford, England)|October 3, 2022
Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 casesYann Nguyen, Cécile M Yelnik, Nathalie Morel, et al.
Medicine|December 16, 2014
Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literatureGuillaume Dumas, Virginie Prendki, Julien Haroche, et al.
JAMA Dermatology|December 8, 2022
Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 PatientsAnastasia Dupré, Nathalie Morel, Cécile Yelnik, et al.
Blood|October 23, 2009
International consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Roberto Stasi, Adrian C Newland, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Blood|October 9, 2014
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patientsMehdi Khellaf, Anaïs Charles-Nelson, Olivier Fain, et al.
Circulation|September 11, 2015
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 PatientsArsene Mekinian, Cloé Comarmond, Mathieu Resche-Rigon, et al.
Pageof 19